Compare Enphase Energy Inc (ENPH) vs Ionis Pharmaceuticals Inc. Common Stock (IONS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enphase Energy Inc vs Ionis Pharmaceuticals Inc. Common Stock — how do they compare? Enphase Energy Inc trades at $28.56 (market cap $4.23B), while Ionis Pharmaceuticals Inc. Common Stock trades at $43.32 (market cap $7.10B). The key difference: Ionis Pharmaceuticals Inc. Common Stock is the larger of the two by market cap, and Enphase Energy Inc is more actively traded (4,755,897 versus 2,027,457). Which is the better fit depends on your goals — on Pluang, investors hold Enphase Energy Inc for 72 Days and Ionis Pharmaceuticals Inc. Common Stock for 0 Days on average.
| ENPH | IONS | |
|---|---|---|
Market Cap | $4.23B | $7.10B |
Volume | 4,755,897 | 2,027,457 |
Sector | Energy | Health |
52-Week High | $72.33 | $86.50 |
52-Week Low | $26.12 | $42.38 |
Typical Hold Time | 72 Days | 0 Days |
Enterprise Value | $3.88B | $6.66B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Enphase Energy (ENPH) trades at $32.03, up 1.71% on the day, but remains in a technical downtrend with a bearish moving average signal. The stock faces pressure from recent earnings misses in Q1 and Q2 2026, though it beat expectations in Q4 2025. Revenue declined from $2.3B in 2023 to $1.47B in 2025, but net income margin improved to 11.68%. Recent news highlights product approvals and expansion into AI data center power solutions, providing potential growth catalysts amid a challenging solar sector environment.
The outlook is mixed; analyst consensus is a Buy with a $42.68 price target, implying significant upside, but high borrowing costs and solar industry headwinds pose risks. The stock's current valuation at a P/E of 31.71 may limit near-term gains if earnings growth stalls. Investors should weigh the company's innovation in smart energy solutions against macroeconomic pressures and competitive dynamics in the renewable energy market.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Enphase Energy Inc
Enphase Energy is a global energy technology company. The company delivers smart, easy-to-use solutions that manage solar generation, storage, and communication on one platform. The company's microinverter technology primarily serves the rooftop solar market and produces a fully integrated solar-plus-storage solution. Geographically, it derives a majority of revenue from the United States.
Read more on ENPH →About Ionis Pharmaceuticals Inc. Common Stock
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →
